本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atrium Therapeutics

14.00
+0.38002.79%
盤後14.000.00000.00%16:10 EDT
成交量:16.66萬
成交額:231.15萬
市值:2.39億
市盈率:-3.63
高:14.05
開:13.72
低:13.41
收:13.62
52周最高:16.77
52周最低:11.13
股本:1,710.56萬
流通股本:1,572.10萬
量比:0.83
換手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-3.8578
每股收益(LYR):-3.1905
淨資產收益率:-43.98%
總資產收益率:-399.25%
市淨率:1.12
市盈率(LYR):-4.39

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/04/27

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/23

重要事件披露

Form 8-K - Current report
2026/02/03

重要事件披露

Form 8-K - Current report